期刊文献+

普拉地平合成工艺研究 被引量:1

Study on Synthesis Process of Pranidipine
下载PDF
导出
摘要 目的:合成新型二氢吡啶类钙拮抗药普拉地平。方法:以双乙烯酮、肉桂醇为原料,通过酯化得到乙酰乙酸肉桂醇酯(3),3与3-硝基苯甲醛缩舍得到3-(3-硝基苯基)之一氧代-3_-戊烯酸肉桂醇酯(2),再与3-氨基-2-丁烯酸甲酯环化得到普拉地平(1)。结果:反应总收率为66.8%。目标化合物的结构经IR、MS和^1H—NMR确证。结论:该工艺路线简单,反应试剂和原料价廉易得,操作方便,适合于工业化生产。 Objective: To synthesize novel dihydropyridine calcium antagonist the pranidipine (1). Method: Diketene and cinnamyl alcohol as the starting material were transformed to cinnamyl acetoaeetate (3) via esterifieation. And 3 with 3-nitrobenzaldehyde was condensed to form 3-( 3-nitrophenyl)- 2-oxo-pentanoic acid- cinnamyl ester (2). 2 with 3-amino-2-butenoic acid methyl ester was cyelized to produce new calcium antagonist pranidipine. Result: The total yield was 66.8%. Pranidipine synthesized had eharaeterized by IR, ^1H-NMR, and MS spectral measurements. Conclusion : This improved procedure has several advantages of low consumption, mild condition, convenient operation, and is suitable for industrial production.
出处 《中国药师》 CAS 2009年第10期1370-1372,共3页 China Pharmacist
关键词 普拉地平 钙拮抗药 合成 Pranidipine Calcium antagonist Synthesis
  • 相关文献

参考文献10

  • 1Nakatsuma A, Kawasaki H, Kurosaki Y, et al. Effects of long-term treated with calcium antagonists on periarterial nerve function in the mesenteric artery of spontaneously hypertensive rats [ J]. Jpn J Pharmacol, 2000, 84 (2) :156- 162.
  • 2Nagasawa M, Sasabe H, Shimizu T, et al. Use of a cartier for quantition of a new dihydropyridine calcium antagonist (0PC-13340) in human plasma by highly sensitive gas chromatography with negative-ion chemical ionization mass spectrometry [ J ]. J Chroma , 1992,577:275 -281.
  • 3Takeuchi K, Omura T, Yoshiyama M. Long-acting calcium channel antigonist pranidipine prevents ventricular remodeling after myocardial infarction in rats [J].Heart Vessels, 1999, 14(3):111-119.
  • 4Moil T, Takase H, Toide K, et al. Paranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation[J]. Cardiovasc Drug Rev, 2001, 19( 1 ) :1-8.
  • 5Toriu N, Sasaoka M, Sehimazawa M, et al. Effects of lomerizine, a novel Ca^2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve head of rabbits [ J ]. J Ocul Pharmavol Ther, 2001, 17 ( 2 ) : 131 - 149.
  • 6Nishitani S, Minamikawa J, KMasanobu, et al. Process for preparing novel dihydropyridine derivatives[P]. EP: 173126,1986-03-05.
  • 7Tamada S, Nagami K, Teramoto S, et al. Novel dihydropyrldine derivatives and process for preparing the same[P]. EP:145434,1985-06-19.
  • 8Nishitani S, Minamikawa J, Kano M,et al. Process for preparing novel dihydropyridine derivatives[P]. US : 4795814,1986-12-18.
  • 9Watanabe D, Fukutani T, Ikawa H. Polymorphism of methyl (E)-3-phenyl-2- propen-1-yl 1,4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate (FBC-8411) [J]. Chem Pharm Bull, 1986, 34(11):4855-4858.
  • 10伍小云,胡艾希,谭英.钙拮抗剂普拉地平合成的改进[J].应用化学,2003,20(10):1015-1017. 被引量:4

二级参考文献3

共引文献3

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部